Menu

GRAIL, Inc. (GRAL) Presents at 2026 UBS Global Healthcare Conference Transcript
📰

GRAIL, Inc. (GRAL) Presents at 2026 UBS Global Healthcare Conference Transcript

All Articles on Seeking Alpha·6 days ago
#GzHMauLb
#seekingalpha#really#aaron#company#douglas
Reading 0:00
15s threshold

GRAIL, Inc. ( GRAL ) 2026 UBS Global Healthcare Conference November 10, 2026 11:00 AM EST

Company Participants

Aaron Freidin - CFO & Head of Corporate Development

Conference Call Participants

Douglas Schenkel - UBS Investment Bank, Research Division

Presentation

Douglas Schenkel

UBS Investment Bank, Research Division

All right. Good morning. I'm Doug Schenkel. It's my pleasure to welcome Aaron Frieden, CFO of GRAIL. Aaron, thank you for being here.

Aaron Freidin

CFO & Head of Corporate Development

Yes. Thanks for having us, Doug.

Question-and-Answer Session

Douglas Schenkel

UBS Investment Bank, Research Division

So as GRAILS's test Gelleri moves through FDA review. The key debate is really what approval could unlock from a reimbursement perspective, how important that is to driving broader adoption and how this positions you and others more broadly in the context of multi-cancer screening. It is a massive opportunity. It could make a huge difference for the general population in the U.S.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.